Zioptan FDA Approval History
FDA Approved: Yes (First approved February 10, 2012)
Brand name: Zioptan
Generic name: tafluprost
Dosage form: Ophthalmic Solution
Company: Merck & Co., Inc.
Treatment for: Glaucoma, Open Angle, Intraocular Hypertension
Zioptan (tafluprost ophthalmic solution) is a prostaglandin analog indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Development timeline for Zioptan
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.